Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...] …
Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] …
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...] …
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...] …
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] …